Lantern Pharma Inc. (LTRN) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $11.04M | -56.8% |
| 2024 | $25.57M | -41.4% |
| 2023 | $43.65M | -25.8% |
| 2022 | $58.84M | -20.4% |
| 2021 | $73.95M | +263.2% |
| 2020 | $20.36M | +1321.2% |
| 2019 | $1.43M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $11.04M | -56.8% |
| 2024 | $25.57M | -41.4% |
| 2023 | $43.65M | -25.8% |
| 2022 | $58.84M | -20.4% |
| 2021 | $73.95M | +263.2% |
| 2020 | $20.36M | +1321.2% |
| 2019 | $1.43M | — |